# NCore Ventures

> NCore Ventures is a VC fund in Seoul backing Biotechnology and Artificial Intelligence. See 15 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Seoul, South Korea
- Total investments: 15
- Last investment: Feb 2026
- Lead investor: 13%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/ncore-ventures/
- Website: http://ncorevc.com/

NCore Ventures is an investment firm

## Round sizes

| Stage | Round size |
| --- | --- |
| Series B | $5M–$184M |
| Series C | $25M–$360M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 3 | 20% |
| Artificial Intelligence | 3 | 20% |
| Software | 2 | 13% |
| Marketing | 2 | 13% |
| Machine Learning | 2 | 13% |

50 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 7 | 47% |
| Seed | 2 | 13% |
| Series C | 2 | 13% |
| Series A | 1 | 7% |
| Series D | 1 | 7% |

7 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| South Korea | 5 | 33% |
| Singapore | 3 | 20% |
| Vietnam | 2 | 13% |
| United States | 2 | 13% |
| Japan | 1 | 7% |

6 countries tracked in total.

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Galux | Galux provides molecular design technology focusing on discovering and developing novel drugs for incurable and rare diseases using its AI-based drug design platform technologies. | $29M | Series B | Feb 09, 2026 |  |
| Playtag | Playtag operates an AI-based platform that uses behavioral analytics for early childhood education. The company develops learning tools for infants and toddlers and provides systems for kindergartens and daycare centers. These systems support the use of data-driven methods in teaching and classroom activities. | $4.4M | Venture - Series Unknown | Nov 25, 2025 |  |
| GOPIZZA | GOPIZZA operates service restaurants specializing in single-serving pizzas with preparation systems and delivery-focused operations. The company develops compact store formats designed for dine-in, takeaway, and food delivery services. With operations across several international markets, GOPIZZA continues expanding its restaurant network anddigital ordering capabilities. | $25M | Series C | Oct 17, 2022 |  |
| OpenExchange | OpenExchange is a SaaS solution that enhances the interaction between the investment community and public companies through our cloud-based video conferencing service. The online network offers clients the ability to search a global directory of financial services professionals, schedule video meetings, and meet over a wide range of videoendpoints, including desktop/laptop, video conference rooms, and mobile devices. Clients include investment managers, investment banks, and public companies. | $23M | Series D | Jun 17, 2021 |  |
| Carro | Carro is an online used car marketplace that offers a wide range of services for buying a car. | $360M | Series C | Jun 15, 2021 |  |
| Rebus Biosystems | Rebus Biosystems is a venture-backed Silicon Valley-based life science technology company creating revolutionary tools to enable spatial omics research without compromise. The company’s first instrument, the Rebus Esper, is a fully integrated, automated spatial omics platform that delivers quantitative single molecule, single-cell data withsubcellular resolution. Advanced imaging, on-system chemistry, and intuitive software have been combined to provide an end-to-end solution requiring minimal hands-on time. Rebus Biosystems provides all-inclusive assay kits to empower researchers with the resolution, scale and speed of the Rebus Esper for multiple applications. Learn more at www.rebusbio.com. | $20M | Series B | Nov 19, 2020 |  |
| Brite Energy Partners | Brite Energy Partners develops a clean energy platform that offers a solar income plan for landowners, project owners, and building owners. | $3M | Series A | Sep 10, 2020 |  |
| VeXeRe.Com | Founded in 2013, VeXeRe.com is the largest online bus ticket platform in Vietnam. They help passengers book bus tickets conveniently thanks to their 1,000+ bus companies network and coverage for trips within Vietnam and from Vietnam to neighbor countries. Their payment channels include online payment, payment at 24/7 convenience stores, banktransfers, and other channels that provide customers with convenient booking experience. |  |  | Dec 25, 2019 |  |
| Collab Asia | Positioned at the nexus of content, platforms, and brands, Collab Asia seeks to lead the digital transformation of media in Asia by improving the way content is created, distributed, and consumed. As the leading digital media and influencer agency in APAC, our mission is to shape the future of our industry and make the greatest impact possible byproducing cutting-edge solutions for content creators, media platforms, and top brands in today’s rapidly developing digital ecosystem. Our international team of 200+ in-house professionals and our network of 4000+ social media influencers operate across 8 Asia-Pacific offices, including Seoul, Tokyo, Jakarta, Hong Kong, Manila, Singapore, Kuala Lumpur, Shenzhen, and Los Angeles. Combining our local expertise with our global perspective, we're uniquely equipped to produce marketing solutions that are distributed across multiple geographies and platforms to reach a wider audience. We strive to deliver the best possible service, and aim to be the strongest and most innovative digital media company in Asia. | $7.5M | Series B | Nov 03, 2019 |  |
| Cogent Labs | Cogent Labs, a Tokyo based AI company, bridges the gap between state-of-the-art artificial intelligence and real-world solutions with a mission to improve people’s quality of life. The company conducts advanced fundamental and applied AI research to create business solutions leveraging expertise across many fields, including time-seriesforecasting, information extraction, natural language and voice processing, and reinforcement learning. | $184.3M | Series B | May 23, 2019 |  |

10 of 15 investments shown.

## Co-investors
- [Access Ventures](https://shizune.co/investors/profile/access-ventures-llc) — VC Fund, 2 deals together
- [Golden Gate Ventures](https://shizune.co/investors/profile/golden-gate-ventures) — VC Fund, 2 deals together
- [Samsung Ventures](https://shizune.co/investors/profile/samsung-ventures) — VC Fund, 2 deals together
- [Alpha JWC Ventures](https://shizune.co/investors/profile/alpha-jwc-ventures) — VC Fund, 1 deal together
- [Altos Ventures](https://shizune.co/investors/profile/altos-ventures) — VC Fund, 1 deal together
- [B Capital](https://shizune.co/investors/profile/b-capital-group) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

### Similar country
- [Strong Ventures](https://shizune.co/investors/profile/strong-ventures) — VC Fund
- [Korea Credit Guarantee Fund](https://shizune.co/investors/profile/korea-credit-guarantee-fund) — VC Fund
- [Kakao Ventures](https://shizune.co/investors/profile/kakao-ventures) — VC Fund

## Featured in investor lists
- [Health Care Investors in South Korea](https://shizune.co/investors/health-care-investors-south-korea)
- [Health Care VC Funds in South Korea](https://shizune.co/investors/health-care-vc-funds-south-korea)
- [Biotech Investors in South Korea](https://shizune.co/investors/biotech-investors-south-korea)
- [Biotech VC Funds in South Korea](https://shizune.co/investors/biotech-vc-funds-south-korea)
- [Biotechnology Investors in South Korea](https://shizune.co/investors/biotechnology-investors-south-korea)
- [Biotechnology VC Funds in South Korea](https://shizune.co/investors/biotechnology-vc-funds-south-korea)

## FAQ

### What does NCore Ventures invest in?

NCore Ventures invests primarily in Biotechnology, Artificial Intelligence and Software startups, most often at Series B and Seed stage. Most of the 15 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is NCore Ventures's check size?

NCore Ventures typically joins rounds of $5M–$184M at Series B and $25M–$360M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds NCore Ventures participates in.

### When did NCore Ventures last invest?

The most recent investment recorded for NCore Ventures closed in Feb 2026. Shizune tracks 15 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co